An independent intelligence board aggregating credible research, preprints, clinical findings, biohacking experiments, and community discussions on therapeutic peptides, longevity science, and evidence-based anti-aging. Stories are scored for relevance, credibility, novelty, momentum, and practicality so the most important findings surface first.
A recent headline is promoting a combo of two experimental bodybuilding compounds — RAD-140 (also called Testolone) and ibutamoren (also called MK-677) — as an effective “stack” for bulking and muscle growth in 2025. The story appears to be a promotional-style piece rather than a new clinical trial report. It references these compounds as marketed for muscle gain, but it doesn’t present strong new human trial data in the snippet provided. RAD-140 is a type of SARM (selective androgen receptor modulator). In plain terms, it’s a lab-made molecule that can stick to the same body receptors that testosterone does. The idea is to get some of testosterone’s muscle-building effects while avoiding some of its other effects elsewhere in the body. Ibutamoren (MK-677) is not a SARM but a growth-hormone secretagogue — it tells the body to release more growth hormone and IGF-1, which can increase appetite and may help with muscle and bone. Neither of these is an approved prescription medicine for building muscle. What the research actually shows is mixed and limited. There are animal studies and small human studies for each compound, and much of the public discussion comes from lab work, bodybuilding reports, and early-phase trials rather than large, long-term randomized studies. Some studies suggest potential for increased lean mass or hormone changes, but effects in real-world, supervised human use and impacts on strength, function, and long-term health are not well-established. The promotional angle of “effective for bulking in 2025” goes beyond what rigorous evidence currently supports. Why it matters is straightforward: people seeking faster muscle gains may be tempted to try these products, especially because they are often sold online without prescriptions. For athletes, casual gym-goers, or anyone chasing body-change shortcuts, claims about potent, “selective” drugs sound attractive. It’s also relevant to public health because unregulated use can lead to hidden side effects, positive drug tests for athletes, and unknown long-term consequences. There are important caveats and risks. RAD-140 and ibutamoren are not approved by major regulators for muscle-building; many products sold as SARMs are unregulated and may be mislabeled or contaminated. Short-term side effects reported in studies and user reports include hormonal disruption, changes in cholesterol, liver enzyme alterations, increased appetite, and potential cardiovascular risk markers. Long-term safety is largely unknown. People who are pregnant, breastfeeding, under 18, or with liver, heart, or hormonal conditions should avoid these substances. Because quality and dosing are inconsistent in unregulated markets, anyone considering them faces safety and legal uncertainties. Bottom line: these compounds are hyped for bulking, but solid, long-term human evidence and safety data are lacking, so caution is warranted.
Source: Yahoo Finance